Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Eller

Showing results (81-90 of 145) with videos related to

Pageof 15
Sort By:
Immunity|January 23, 2016
Circulating HIV-Specific Interleukin-21(+)CD4(+) T Cells Represent Peripheral Tfh Cells with Antigen-Dependent Helper FunctionsBruce T Schultz, Jeffrey E Teigler, Franco Pissani, et al.
Journal of Virology|March 18, 2011
Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motifMichael A Eller, Rebecca N Koehler, Gustavo H Kijak, et al.
Plos One|December 17, 2008
Reference intervals in healthy adult Ugandan blood donors and their impact on conducting international vaccine trialsLeigh Anne Eller, Michael A Eller, Benson Ouma, et al.
Journal of Virology|September 15, 2017
Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral InfectionJeffrey E Teigler, Gennadiy Zelinskyy, Michael A Eller, et al.
JCI Insight|May 18, 2018
Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir sizeJeffrey E Teigler, Louise Leyre, Nicolas Chomont, et al.
Tissue Antigens|March 4, 2009
HLA class I allele and haplotype diversity in Ugandans supports the presence of a major east African genetic clusterG H Kijak, A M Walsh, R N Koehler, et al.
Plos One|September 28, 2011
A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cellsMichael A Eller, Bonnie M Slike, Josephine H Cox, et al.
The Journal of Infectious Diseases|August 31, 2018
Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus-Infected KenyansAndrew Letizia, Michael A Eller, Christina Polyak, et al.
AIDS (London, England)|June 1, 2023
Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector function magnitude but not durabilityZhanna Shubin, Sherry Stanfield-Oakley, Jiraporn Puangkaew, et al.
Journal of Neurovirology|August 31, 2019
Monocyte activation, HIV, and cognitive performance in East AfricaL Arnoldo Muñoz-Nevárez, Brandon M Imp, Michael A Eller, et al.
Pageof 15

Showing results (81-90 of 145) with videos related to

Sort By:
Pageof 15
Immunity|January 23, 2016
Circulating HIV-Specific Interleukin-21(+)CD4(+) T Cells Represent Peripheral Tfh Cells with Antigen-Dependent Helper FunctionsBruce T Schultz, Jeffrey E Teigler, Franco Pissani, et al.
Journal of Virology|March 18, 2011
Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motifMichael A Eller, Rebecca N Koehler, Gustavo H Kijak, et al.
Plos One|December 17, 2008
Reference intervals in healthy adult Ugandan blood donors and their impact on conducting international vaccine trialsLeigh Anne Eller, Michael A Eller, Benson Ouma, et al.
Journal of Virology|September 15, 2017
Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral InfectionJeffrey E Teigler, Gennadiy Zelinskyy, Michael A Eller, et al.
JCI Insight|May 18, 2018
Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir sizeJeffrey E Teigler, Louise Leyre, Nicolas Chomont, et al.
Tissue Antigens|March 4, 2009
HLA class I allele and haplotype diversity in Ugandans supports the presence of a major east African genetic clusterG H Kijak, A M Walsh, R N Koehler, et al.
Plos One|September 28, 2011
A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cellsMichael A Eller, Bonnie M Slike, Josephine H Cox, et al.
The Journal of Infectious Diseases|August 31, 2018
Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus-Infected KenyansAndrew Letizia, Michael A Eller, Christina Polyak, et al.
AIDS (London, England)|June 1, 2023
Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector function magnitude but not durabilityZhanna Shubin, Sherry Stanfield-Oakley, Jiraporn Puangkaew, et al.
Journal of Neurovirology|August 31, 2019
Monocyte activation, HIV, and cognitive performance in East AfricaL Arnoldo Muñoz-Nevárez, Brandon M Imp, Michael A Eller, et al.
Pageof 15